参考文献/References:
[1]Singh D,Agusti A,Anzueto A,et al.Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019[J].Eur Respir J,2019,53(5):1900164.[2]Wang C,Xu J,Yang L,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J].Lancet,2018,391(10131):1706-1717.[3]Zhou M,Wang H,Zeng X,et al.Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2019,394(10204):1145-1158.[4]Barnes PJ.Inflammatory mechanisms in patients with chronic obstructive pulmonary disease[J].J Allergy Clin Immunol,2016,138(1):16-27.[5]Sivapalan P,Lapperre TS,Janner J,et al.Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial[J].Lancet Respir Med,2019,7(8):699-709.[6]Keatings VM,Barnes PJ.Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects[J].Am J Respir Crit Care Med,1997,155(2):449-453.[7]Fahy JV,Dickey BF.Airway mucus function and dysfunction[J].N Engl J Med,2010,363(23):2233-2247.[8]Rahimi-Rad MH,Soltani S,Rabieepour M,et al.Thrombocytopenia as a marker of outcome in patients with acute exacerbation of chronic obstructive pulmonary disease[J].Pneumonol Alergol Pol,2015,83(5):348-351.[9]蒋玉洁,罗维贵,许建国,等.慢性阻塞性肺疾病患者外周血中性粒细胞/淋巴细胞比值变化及其与全身炎症反应的关系[J].右江医学,2015,43(3):265-269.[10]Sahin F,Ko?孜ar AF,Aslan AF,et al.Serum Biomarkers in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Comparative Study[J].J Med Biochem,2019,38(4):503-511.[11]Long J,Ouyang Y,Duan H,et al.Multiple Factor Analysis of Depression and/or Anxiety in Patients with Acute Exacerbation Chronic Obstructive Pulmonary Disease[J].Int J Chron Obstruct Pulmon Dis,2020,15:1449-1464.[12]In E,Kulu?觟ztürk M,?魻ner ?魻,et al.The Importance of Neutrophil-to-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease[J].Turk Thorac J,2016,17(2):41-46.[13]Paliogiannis P,Fois AG,Sotgia S,et al.The neutrophil-to-lymphocyte ratio as a marker of chronic obstructive pulmonary disease and its exacerbations: A systematic review and meta-analysis[J].Eur J Clin Invest,2018,48(8):e12984.[14]Lee SJ,Lee HR,Lee TW,et al.Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study[J].Korean J Intern Med,2016,31(5):891-898.[15]Farah R,Ibrahim R,Nassar M,et al.The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD[J].Panminerva Med,2017,59(3):203-209.[16]孟凡亮,郭太平,高建荣,等.外周血NLR、D-二聚体、hs-CRP与慢性阻塞性肺疾病的相关性研究[J].临床肺科杂志,2019,24(8):1438-1441.[17]Lu FY,Chen R,Li N,et al.Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators[J].Int J Chron Obstruct Pulmon Dis,2021,16:341-349.[18]Sakurai K,Chubachi S,Irie H,et al.Clinical utility of blood neutrophil-lymphocyte ratio in Japanese COPD patients[J].BMC Pulm Med,2018,18(1):65.[19]Pascual-González Y,López-Sánchez M,Dorca J,et al.Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review[J].Int J Chron Obstruct Pulmon Dis,2018,13:3651-3662.[20]Yao C,Liu X,Tang Z.Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD[J].Int J Chron Obstruct Pulmon Dis,2017,122285-122290.[21]Teng F,Ye H,Xue T.Predictive value of neutrophil to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease[J].PLoS One,2018,13(9):e0204377.[22]Xiong W,Xu M,Zhao Y,et al.Can we predict the prognosis of COPD with a routine blood test[J].Int J Chron Obstruct Pulmon Dis,2017,12:615-625.[23]Nuňez A,Marras V,Harlander M,et al.Association Between Routine Blood Biomarkers and Clinical Phenotypes and Exacerbations in Chronic Obstructive Pulmonary Disease[J].Int J Chron Obstruct Pulmon Dis,2020,15:681-690.[24]叶云燕,王欢,王艺沙,等.血清PCT与CRP和血小板对重症感染患者病情程度的评估效果研究[J].中华医院感染学杂志,2019,29(10):1487-1490.[25]Zuo H,Xie X,Peng J,et al.Predictive Value of Novel Inflammation-Based Biomarkers for Pulmonary Hypertension in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Anal Cell Pathol (Amst),2019,2019:5189165.[26]Yasar Z,Buyuksirin M,Ucsular FD,et al.Is an elevated neutrophil-to-lymphocyte ratio a predictor of metabolic syndrome in patients with chronic obstructive pulmonary disease[J].Eur Rev Med Pharmacol Sci,2015,19(6):956-962.[27]叶涛,杨银,王凯,等.中性粒细胞/淋巴细胞比率预测慢性阻塞性肺疾病患者并发2型糖尿病的价值:前瞻性队列研究[J].南方医科大学学报,2017,37(10):1308-1314.[28]Delcea C,Buzea CA,Vijan A,et al.Comparative role of hematological indices for the assessment of in-hospital outcome of heart failure patients[J].Scand Cardiovasc J,2021,55(4):227-236[29]王江莎,肖建军.老年COPD急性加重期患者血小板平均体积与CAPS评分及住院死亡的关系[J].浙江中西医结合杂志,2016,26(2):108-112.[30]Karadeniz G,Aktoｇu S,Erer OF,et al.Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease[J].Biomark Med,2016,10(7):701-710.[31]Hlapｃiｃ I,Somborac-Baｃura A,Popoviｃ-Grle S,et al.Platelet indices in stable chronic obstructive pulmonary disease - association with inflammatory markers, comorbidities and therapy[J].Biochem Med (Zagreb),2020,30(1):010701.[32]Aksoy E,Karakurt Z,Gungor S,et al.Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes[J].Int J Chron Obstruct Pulmon Dis,2018,13:2721-2730.[33]El-Gazzar AG,Kamel MH,Elbahnasy O,et al.Prognostic value of platelet and neutrophil to lymphocyte ratio in COPD patients[J].Expert Rev Respir Med,2020,14(1):111-116.[34]Liu X,Ge H,Feng X,et al.The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease[J].Front Med (Lausanne),2020,7:572435.[35]Kumar P,Law S,Sriram KB.Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease[J].J Thorac Dis,2017,9(6):1509-1516.[36]Rahimirad S,Ghaffary MR,Rahimirad MH,et al.Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease[J].Tuberk Toraks,2017,65(1):25-31.[37]Emami Ardestani M,Alavi-Naeini N.Evaluation of the relationship of neutrophil-to lymphocyte ratio and platelet-to-lymphocyte ratio with in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease[J].Clin Respir J,2021,15(4):382-388. [38]Chen G,Wu C,Luo Z,et al.Platelet-lymphocyte ratios:a potential marker for pulmonary tuberculosis diagnosis in COPD patients[J].Int J Chron Obstruct Pulmon Dis,2016,11:2737-2740.[39]周淑华,刘江燕.老年慢性阻塞性肺疾病急性加重期患者红细胞分布宽度与近期不良预后的相关性[J].中国慢性病预防与控制,2017,25(5):355-357.[40]Aksoy E,Güng?觟r S,Aｇca M?覶,et al.A Revised Treatment Approach for Hospitalized Patients with Eosinophilic and Neutrophilic Exacerbations of Chronic Obstructive Pulmonary Disease[J].Turk Thorac J,2018,19(4):193-200.
相似文献/References:
[1]钟雪梅,李 黎,米热班·热夏提,等.α1-抗胰蛋白酶与维吾尔族慢性阻塞性肺疾病的相关性分析[J].医学信息,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
ZHONG Xue-mei,LI Li,Mirban·rixat,et al.Correlation Analysis of α1-antitrypsin and Uygur Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(11):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
[2]陈文福.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析[J].医学信息,2018,31(02):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
CHEN Wen-fu.Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(11):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
[3]吴仲东.无创机械通气用于COPD合并呼吸衰竭的疗效分析[J].医学信息,2018,31(04):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
WU Zhong-dong.Clinical Analysis of Noninvasive Mechanical Ventilation in Patients with COPD Complicated with Respiratory Failure[J].Medical Information,2018,31(11):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
[4]龙有珠.氨茶碱联合呼吸功能训练治疗慢性阻塞性肺疾病的疗效分析[J].医学信息,2018,31(04):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
LONG You-zhu.Effect of Aminophylline Combined with Respiratory Function Training on Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(11):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
[5]皮鑫鑫,邓 革.临床药师对1例院内感染患者的病例分析[J].医学信息,2018,31(04):188.[doi:10.3969/j.issn.1006-1959.2018.04.072]
[6]罗 倩.COPD加重期患者肺功能、血气指标及
炎症指标的变化分析[J].医学信息,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
LUO Qian.Changes of Pulmonary Function,Blood Gas and Inflammation in Patients with COPD Exacerbation[J].Medical Information,2018,31(11):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
[7]赵志国.有创-无创序贯通气疗法治疗慢性阻塞性肺疾病
引发的严重呼吸衰竭的临床研究[J].医学信息,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
ZHAO Zhi-guo.Clinical Study of Invasive Non-invasive Sequential Ventilation in Treatment of Severe Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
[8]金彦青.NPPV治疗慢性阻塞性肺疾病合并
重症呼吸衰竭的临床疗效观察[J].医学信息,2018,31(14):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
JIN Yan-qing.Clinical Efficacy of NPPV in the Treatment of Chronic Obstructive Pulmonary Disease with Severe Respiratory Failure[J].Medical Information,2018,31(11):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
[9]张 林,白 俐.扶正化瘀胶囊对慢性阻塞性肺疾病患者炎性因子及
MMP-9、TIMP-1的影响[J].医学信息,2018,31(14):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
ZHANG Lin,BAI Li.Effect of Fuzheng Huayu Capsule on Inflammatory Factors,MMP-9 and TIMP-1 in Patients with Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(11):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
[10]张善芳,汤 杰.穴位注射联合沙美特罗替卡松粉吸入剂治疗
慢性阻塞性肺疾病稳定期的临床疗效观察[J].医学信息,2018,31(16):131.[doi:10.3969/j.issn.1006-1959.2018.16.041]
ZHANG Shan-fang,TANG Jie.Clinical Observation of Acupoint Injection Combined with Salmeterol and Fluticasone Powder Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(11):131.[doi:10.3969/j.issn.1006-1959.2018.16.041]
[11]臧传丽,朴红梅.RDW、PLR、NLR及RCI在COPD中的临床意义[J].医学信息,2022,35(15):153.[doi:10.3969/j.issn.1006-1959.2022.15.036]
ZANG Chuan-li,PIAO Hong-mei.Clinical Significance of RDW, PLR, NLR and RCI in Chronic Obstructive Pulmonary Disease[J].Medical Information,2022,35(11):153.[doi:10.3969/j.issn.1006-1959.2022.15.036]